rewire.itbenchmarks
Result

29% benign_reference_assigned_pp3

BRCA1 generic BayesDel threshold comparator: benign_reference_assigned_pp3

Tested configuration
BayesDel generic Pejaver evidence thresholds in ENIGMA comparison
Protocol
BRCA1 generic BayesDel threshold evidence-code assignment
Dataset
BRCA1 functional reference calibration set
Related family profiles
BayesDel
Procedure
Not reported
Evaluation
BRCA1 generic BayesDel threshold comparator
Coverage
scored: unreported; eligible: unreported
Uncertainty
Not reported
Evidence
Author-reported evaluation · source checkedEvidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Results, BayesDel calibration, sentence 29% for BRCA1 and 36% for BRCA2 incorrectly assigned PP3

A source-checked result verifies the numerical transcription, not every model or protocol detail. Evaluation metadata: source checked. Source checked does not mean independently reproduced.

Reproduction

Split
Not reported
Adaptation
Not reported
Scoring implementation
Source-defined endpoint; see result source_locator

No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.

Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

1 evidence row matching the loaded filters

Claims, original sources and review scope · Release 2026-09-30-e37e3ab1284d
Property and statementOriginal source and locationReview and provenance
Reported result
29%
Individual claims
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

Results, BayesDel calibration, sentence 29% for BRCA1 and 36% for BRCA2 incorrectly assigned PP3

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

source checked

automated source review · 2026-09-30

author reported

Audit details

Transcription from inspected primary source. No execution, independent replication or human scientific review.

Field: attributes.printed_value

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

View linked audit checks and correction history

Release 2026-09-30-e37e3ab1284d · Record review: source checked

1 source records and release historyDownload this release
Technical metadata and extraction receipts

Stable ID: uc-clinical-20260930-enigma-brca1-generic-false-pp3

areas
dna-genomes
contexts
clinical_research
metric
benign_reference_assigned_pp3
unit
percent
printed value
29%
numeric value
29
metric direction
lower
uncertainty
Not reported
source locator
Results, BayesDel calibration, sentence 29% for BRCA1 and 36% for BRCA2 incorrectly assigned PP3
review
method: automated_source_review; reviewer: Codex clinical coverage worker; date: 2026-09-30; note: Transcription from inspected primary source. No execution, independent replication or human scientific review.; source id: uc-clinical-20260930-source-enigma
criterion
PP3 supporting threshold ≥0.13
denominator
1278
missing metadata
uncertainty: not reported for this endpoint
Related records

Suggest a correction